National Coverage Determination (NCD)

Lymphocyte Mitogen Response Assays

190.8

Expand All | Collapse All

Tracking Information

Publication Number
100-3
Manual Section Number
190.8
Manual Section Title
Lymphocyte Mitogen Response Assays
Version Number
1
Effective Date of this Version
05/16/1983

Description Information

Benefit Category
Diagnostic Laboratory Tests


Please Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

Item/Service Description

The lymphocyte mitogen response assay measures the immune response of patient peripheral blood lymphocytes.

Indications and Limitations of Coverage

It is a covered test under Medicare when it is medically necessary to assess lymphocytic function in diagnosed immunodeficiency diseases and to monitor immunotherapy.

It is not covered when it is used to monitor the treatment of cancer, because its use for that purpose is experimental.

Transmittal Information

Revision History

03/2013 - CMS translated the information for this policy from ICD-9-CM/PCS to ICD-10-CM/PCS according to HIPAA standard medical data code set requirements and updated any necessary and related coding infrastructure. These updates do not expand, restrict, or alter existing coverage policy. Implementation date: 10/07/2013 Effective date: 10/1/2015. (TN 1199) (TN 1199) (CR 8197)

05/2014 - CMS translated the information for this policy from ICD-9-CM/PCS to ICD-10-CM/PCS according to HIPAA standard medical data code set requirements and updated any necessary and related coding infrastructure. These updates do not expand, restrict, or alter existing coverage policy. Implementation date: 10/06/2014 Effective date: 10/1/2015. (TN 1388) (TN 1388) (CR 8691)

Additional Information

Other Versions
Title Version Effective Between
Lymphocyte Mitogen Response Assays 1 05/16/1983 - N/A You are here